Nisco et al. Journal of Immunology 92:5845-5849, Apr. 1994. |
Kunimatsu et al. Biochemical and Biophysical Research 164(2):875-882, Oct. 1989. |
Parker et al. Journal of Immunology 149:3580-87, Dec. 1992. |
Englehard, V.H. Current Opinion in Immunol. 6:13-23, 1994. |
Burgess et al. The Journal of Cell Biology 111:2129-38, Nov. 1990. |
Lazar et al Molecular and Cellular Biology 8(3):1247-52, Mar. 1988. |
Kumar et al. PNAS 87:1337-1341, Feb. 1990. |
Salgaller et al. Cancer Immunol. Immunother. 39(2):105-116, Aug. 1994. |
Van der Bruggen et al., "A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes On a Human Melanoma", Science 254: 1643-1647 (Dec. 1991). |
Khanna et al., "Localization of Epstein-Barr Virus Cytotoxic T Cell Epitopes Using Recombinant Vaccinia: Implications for Vaccine Development", J. Exp. Med. 176: 169-176 (Jul. 1992). |
Kita et al., "HLA-B44-restricted Cytotoxic T Lymphocytes Recognizing An Epitope on Hepatitis C Virus Nucleocapsid Protein", Hepatology 18(5): 1039-1044 (1993). |
Thorpe, et al., "Prediction of an HLA-B44 Binding Motif By The Alignment of Known Epitopes And Molecular Modeling of The Antigen Binding Cleft", Immunogenetics 40: 303-305 (1994). |
Fleischauer, et al., "Characterization of Natural Peptide Ligands for HLA-B4402 and -B4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain", Tissue Antigens 44: 311-317 (1994). |
Ramensee et al., "MHC Ligands And Peptides Motifs: First Listing", Immunogenetics 41: 178-228 (1995). |